New insider Sindex Ssi Lending, Llc claimed ownership of 7,943,585 shares (SEC Form 3)
$PMI
Medical/Dental Instruments
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 08/11/2025 |
3. Issuer Name and Ticker or Trading Symbol
Picard Medical, Inc. [ PMI ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock, par value $0.0001 per share | 7,943,585 | D(1) | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
| Explanation of Responses: |
| 1. These shares are held by Sindex SSI Lending, LLC, a Delaware limited liability company ("Sindex"). Versa Capital Fund III, L.P. ("CF III") is the sole member of Sindex. Versa FGP-III, L.P. ("FGP-III") is the general partner of CF III. Versa UGP-III, LLC ("UGP-III") is the general partner of FGP-III. Versa Capital Group, LLC ("Versa") is the sole member of UGP-III. Gregory L. Segall ("Mr. Segall," and together with Sindex, CF III, FGP-III, UGP-III, and Versa, the "Reporting Persons") has voting and dispositive power over shares held by Versa. |
| Remarks: |
| The filing of this Statement shall not be construed as an admission by any Reporting Person (a) that such person is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person. Each of the Reporting Persons disclaims beneficial ownership of any securities covered by this Statement except to the extent of such person's pecuniary interest in such securities. Exhibit List: Exhibit 24.1 - Power of Attorney |
| /s/ Randall Schultz, Authorized Agent for Sindex SSI Lending, LLC | 11/13/2025 | |
| /s/ Randall Schultz, Authorized Agent for Versa Capital Fund III, L.P. | 11/13/2025 | |
| /s/ Randall Schultz, Authorized Agent for Versa FGP-III, L.P. | 11/13/2025 | |
| /s/ Randall Schultz, Authorized Agent for Versa UGP-III, LLC | 11/13/2025 | |
| /s/ Randall Schultz, Authorized Agent for Versa Capital Group, LLC | 11/13/2025 | |
| /s/ Randall Schultz, Authorized Agent for Gregory L. Segall, an individual | 11/13/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||